Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00067912
Status:
COMPLETED
Last Update Posted:
2007-05-21
First Post:
2003-08-29
Brief Title:
Duloxetine vs Active Comparator for the Treatment of Depression
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
How duloxetine compares to a medication currently available for the treatment of depression in the treatment of patients with major depressive disorder
The safety of duloxetine and any side effects that might be associated with it
The safety of duloxetine and any side effects that might be associated with it
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| F1J-MC-HMCQ | None | None | None |